About Human in Motion Robotics
Vancouver robotics company developing XoMotion, a self-balancing lower-limb exoskeleton intended to support hands-free mobility and gait training in rehabilitation settings.
Operating context
Human in Motion's current product positioning distinguishes supervised XoMotion-R gait training for spinal-cord-injury rehabilitation from future broader therapeutic and personal-use versions. The platform combines self-balancing movement with an adjustable exoskeleton, hot-swappable batteries and an optional open-control research interface. Clinical adoption remains an active evidence question: the University of Alberta's Glenrose feasibility study, updated in September 2026, is not yet recruiting and estimates a March 2027 start for 16 participants. Its purpose includes safety, functional outcomes and barriers to inpatient and outpatient use. PacifiCan funding supports company scale-up, while the official product site continues to state that XoMotion is not FDA-cleared.
